Dr. Meijing Wu is described by friends and colleagues as a distinguished biostatistician and “a kind and generous friend who ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.

After he stopped responding to several different therapies aimed at prolonging his life, doctors advised him to try a drug ...

Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

The Research Ireland Centre for Pharmaceuticals (SSPC) has partnered with Ireland ... Eli Lilly Janssen, MSD, Pfizer, and ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Sanofi will take the lead co-commercialization role for our ... During the third quarter, Novavax entered into a material ...

The program taps into several OpenAI models and can be used across a wide range of therapeutic indications. Both Big Pharma ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in ...